High Costs, Low Margins, and Regulatory Hurdles Hinder Pharma’s Adoption of Advanced Manufacturing Technologies

Benchmark Banner Ad

 

The ongoing drug shortage crisis in the U.S. underscores a critical need for innovation in pharmaceutical manufacturing. As manufacturing issues, outdated technologies, and geopolitical risks contribute to shortages that impact patient care and elevate healthcare costs, the introduction of Advanced Manufacturing Technologies (AMTs) offers a beacon of hope. AMT technologies promise to enhance quality control and reduce production downtime, yet their adoption in generic drug production remains low despite obvious benefits.

Why is the pharmaceutical industry slow to adopt technologies that could revolutionize drug availability and cost?

Mike Tracy, a C-Level Healthcare Operations Strategist, dives into the complexities of integrating Advanced Manufacturing Technologies in drug production. Mike points out that while AMTs can drastically reduce bottlenecks in drug production, the significant initial investment and stringent regulatory landscape pose substantial hurdles.

“Every AMT has a high startup cost and generic drugs have very razor-thin margins to begin with. We’re not talking about a new drug that’s not already out in the market where you’re going to have a high margin and it makes sense to invest millions,” Tracy explains.

Article written by Sonia Gossai

Follow us on social media for the latest updates in B2B!

Image

Latest

customer movement
Bonfire Branding: How Solo Stove Sparked a Customer Movement with Liz Vanzura (Episode Three)
January 22, 2026

As audiences tune out polished ads and lean into trust, brands are being forced to rethink how they show up for the customer. Research consistently shows that consumers rate peer-created content as more credible than traditional brand messaging, and algorithmic discovery is increasingly rewarding authenticity over polish. With AI reshaping how people search and…

Read More
supply chains
Why the Best Careers Are Designed Like Resilient Supply Chains
January 22, 2026

What do supply chains and community have in common? They both deliver value—when managed with purpose. At their best, they show how intentional systems, meaningful connections, and consistent action turn effort into lasting professional growth. This week on Professional Quotient, listeners hear from Nathan Chaney, founder of Supply Chaney, whose insights bridge the mechanics…

Read More
brand
Bonfire Branding: How Solo Stove Sparked a Customer Movement with Liz Vanzura (Episode Two)
January 22, 2026

As people seek relief from constant digital noise, the backyard has quietly become a modern “third space” in everyday life. Outdoor living, fire pits, and at-home hosting continue to grow as consumers prioritize connection, ease, and experiences that feel meaningful without requiring more complexity. Brands that understand this shift aren’t just selling products—they’re offering…

Read More
Image
The Retrofit Advantage: B2B Renovation Strategies Powering Retail, Healthcare, Sports, IoT, Energy, ProAV, Engineering, and Construction
January 20, 2026

Innovation is no always a new build. In B2B, the fastest return often comes from upgrading existing facilities without pausing operations for months. Renovation and retrofit projects have become a core business lever because they influence measurable outcomes: energy consumption, staff productivity, customer throughput, uptime, safety, compliance, and lifecycle maintenance costs. Below is a B2B…

Read More